Abstract
The aim of this work was to evaluate the possibility of editing the CD209 gene associated with bovine leukemia virus (BLV) infection. Two ways of delivering the gene editing system into the zygote were investigated: delivery of the CRISPR/Cas9 system using a viral vector and injection of mRNA and sgRNA into the oocyte cytoplasm. The most effective was the microinjection of spCas9 protein mRNA and sgRNA targeting CD209 at the zygote stage into the cytoplasm.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
